Abstract
Recent genome-wide association studies (GWAs) have identified several new genetic risk factors for asthma; however, their influence on disease behavior and treatment response is still unclear. The aim of our study was the association analysis of the most significant single nucleotide polymorphisms (SNPs) recently reported by GWAs in different phenotypes of childhood asthma and analysis of correlation between these SNPs and clinical parameters. We have genotyped 288 children with asthma and 276 healthy controls. We provided here first replication of bivariate associations between CA10 (p = 0.001) and SGK493 (p = 0.011) with asthma. In addition, we have identified new correlation between SNPs in CA10, SGK493, and CTNNA3 with asthma behavior and glucocorticoid treatment response. Asthma patients who carried G allele in SNP rs967676 in gene CA10 were associated with more pronounced airway obstruction, higher bronchial hyper-reactivity, and increased inflammation. Higher bronchial hyper-reactivity was also associated with C allele in SNP rs1440095 in gene SGK493 but only in nonatopic asthmatics. In addition, we found that patients who carried at least one T allele in SNP rs1786929 in CTNNA3 (p = 0.022) and atopic patients who carried at least one G allele in SNP rs967676 in gene CA10 (p = 0.034) had higher increase in pulmonary function after glucocorticoid therapy. Our results suggest genetic heterogeneity between atopic and nonatopic asthma. We provided further evidence that treatment response in childhood asthma is genetically predisposed, and we report here two novel SNPs in genes CA10 and CTNNA3 as potential pharmacogenetic biomarkers that could be used in personalized treatment in childhood asthma.
Similar content being viewed by others
References
Anderson GP (2008) Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 372:1107–1119
AST - American Thoraric Society (1987) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136:225–244
Berce V, Potocnik U (2010a) Association of Q551R polymorphism in the interleukin 4 receptor gene with nonatopic asthma in Slovenian children. Wien Klin Wochenschr 122:11–18
Berce V, Potocnik U (2010b) Functional polymorphism in CTLA4 gene influences the response to therapy with inhaled corticosteroids in Slovenian children with atopic asthma. Biomarkers 15:158–166
Berce V, Repnik K, Potocnik U (2008) Association of CCR5-delta32 mutation with reduced risk of nonatopic asthma in Slovenian children. J Asthma 45:780–784
Berce V, Kozmus CE, Potocnik U (2012) Association among ORMDL3 gene expression, 17q21 polymorphism and response to treatment with inhaled corticosteroids in children with asthma. Pharmacogenomics J. doi:10.1038/tpj.2012.36
Bernstein DI, Kashon L, Lummus ZL et al (2013) CTNNA3 (α-catenin) gene variants are associated with diisocyanate asthma: a replication study in a Caucasian worker population. Toxicol Sci 131:242–246
Bottema RW, Reijmerink NE, Koppelman GH, Kerkhof M, Postma DS (2005) Phenotype definition, age, and gender in the genetics of asthma and atopy. Immunol Allergy Clin North Am 25:621–639
Bottini N, Ronchetti F, Gloria-Bottini F, Stefanini L, Bottini E, Lucarini N (2005) Atopic and nonatopic asthma in children. J Asthma 42:25–28
Busse WW, Lemanske Jr RF (2001) Asthma. N Engl J Med 344:350–362
Cantero-Recasens G, Fandos C, Rubio-Moscardo F, Valverde MA, Vicente R (2010) The asthma-associated ORMDL3 gene product regulates endoplasmic reticulum-mediated calcium signaling and cellular stress. Hum Mol Genet 19:111–121
Castro-Giner F, Bustamante M, Ramon GJ et al (2009) A pooling-based genome-wide analysis identifies new potential candidate genes for atopy in the European Community Respiratory Health Survey (ECRHS). BMC Med Genet 10:128
Child F, Lenney W, Clayton S et al (2003) Correction of bronchial challenge data for age and size may affect the results of genetic association studies in children. Pediatr Allergy Immunol 14:193–200
Cohen P (2002) Protein kinases—the major drug targets of the twenty-first century? Nat Rev Drug Discov 1:309–315. doi:10.1038/nrd773
Demeo DL, Lange C, Silverman EK et al (2002) Univariate and multivariate family-based association analysis of the IL-13 ARG130GLN polymorphism in the Childhood Asthma Management Program. Genet Epidemiol 23:335–348
EST database (2013) http://www.ncbi.nlm.nih.gov/nucest/BX281234?report=genbank. Accessed 8 Dec 2013
Fryer AA, Spiteri MA, Bianco A et al (2000) CCL5/RANTES chemokine gene promoter polymorphisms are not associated with atopic and nonatopic asthma in a Spanish population. Genes Immun 1:509–514
Galanter J, Choudhry S, Eng C et al (2008) ORMDL3 gene is associated with asthma in three ethnically diverse populations. Am J Respir Crit Care Med 177:1194–1200
Gu ML, Zhao J (2011) Mapping and localization of susceptible genes in asthma. Chin Med J 124:132–143
Hancock DB, Romieu I, Shi M et al (2009) Genome-wide association study implicates chromosome 9q21.31 as a susceptibility locus for asthma in Mexican children. PLoS Genet 5:e1000623
Hancock DB, Eijgelsheim M, Wilk JB et al (2010) Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet 42s:45–52
Hashimoto T, Akiyama K, Kobayashi N, Mori A (2005) Comparison of IL-17 production by helper T cells among atopic and nonatopic asthmatics and control subjects. Int Arch Allergy Immunol, 137(Suppl1):51–54
He JQ, Chan-Yeung M, Becker AB et al (2003) Genetic variants of the IL13 and IL4 genes and atopic diseases in at-risk children. Genes Immun 4:385–389
Heinzmann A, Mao XQ, Akaiwa M et al (2000) Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet 9:549–559
Hoffjan S, Ober C (2002) Present status on the genetic studies of asthma. Curr Opin Immunol 14:709–717
Howard TD, Whittaker PA, Zaiman AL et al (2001) Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. Am J Respir Cell Mol Biol 25:377–384
Hrdlickova B, Holla LI (2011) Relationship between the 17q21 locus and adult asthma in a Czech population. Hum Immunol 72:921–925
Ito K, Chung KF, Adcock IM (2006) Update on glucocorticoid action and resistance. J Allergy Clin Immunol 117:522–543
Jostins J, Ripke S, Weersma RK et al (2012) Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491:119–124
Kabesch M, Schedel M, Carr D et al (2006) IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. J Allergy Clin Immunol 117:269–274
Karjalainen J, Hulkkonen J, Neiminen MM et al (2003) Interleukin-10 gene promoter region polymorphism is associated with eosinophil count and circulating immunoglobulin E in adult asthma. Clin Exp Allergy 33:78–83
Kiley J, Smith R, Noel P (2007) Asthma phenotypes. Curr Opin Pulm Med 13:19–23
Kim SH, Cho BY, Park CS et al (2009) Alpha-T-catenin (CTNNA3) gene was identified as a risk variant for toluene diisocyanate-induced asthma by genome-wide association analysis. Clin Exp Allergy 39:203–212
LaBINAEpEPR NH (1991) Guidlines for the diagnosis and management of asthma. J Allergy Clin Immunol 88:425–534
Li X, Howard TD, Zheng SL et al (2010) Genome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regions. J Allergy Clin Immunol 125:328–335
Liu S, Li T, Liu J (2012a) Interleukin-4 rs2243250 polymorphism is associated with asthma among Caucasians and related to atopic asthma. Cytokine 59:364–369
Liu M, Subramanian V, Christie C, Castro M, Mohanakumar T (2012b) Immune responses to self-antigens in asthma patients: clinical and immunopathological implications. Hum Immunol 73:511–516
Lück H, Kinzig M, Jetter A, Fuhr U, Sörgel F (2009) Mesalazine pharmacokinetics and NAT2 phenotype. Eur J Clin Pharmacol 65:47–54
Madore AM, Laprise C (2010) Immunological and genetic aspects of asthma and allergy. J Asthma Allergy 3:107–121
March ME, Sleiman PM, Hakonarson H (2011) The genetics of asthma and allergic disorders. Discov Med 11(56):35–45
Marsh DG, Neely JD, Breazeale DR et al (1994) Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 264:1152–1156
Moffatt MF, Kabesch M, Liang L et al (2007) Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 448(7152):470–473
Mori S, Kou I, Sato H et al (2009) Nucleotide variations in genes encoding carbonic anhydrase 8 and 10 associated with femoral bone mineral density in Japanese female with osteoporosis. J Bone Miner Metab 27(2):213–216
Muro M, Marín L, Torio A, Pagan JA, Alvarez-López MR (2008) The −403 G—a promoter polymorphism in the RANTES gene is associated with atopy and asthma. Int J Immunogenet 35(1):19–23
Nagy A, Kozma GT, Bojszko A, Krikovszky D, Falus A, Szalai C (2002) No association between asthma or allergy and the CCR5Delta 32 mutation. Arch Dis Child 86(6):426
O’Donnell AR, Toelle BG, Marks GB et al (2004) Age-specific relationship between CD14 and atopy in a cohort assessed from age 8 to 25 years. Am J Respir Crit Care Med 169:615–622
Ober C, Yao TC (2011) The genetics of asthma and allergic disease: a 21st century perspective. Immunol Rev 242:10–30
Perin P, Berce V, Potocnik U (2011) CD14 gene polymorphism is not associated with asthma but rather with bronchial obstruction and hyperreactivity in Slovenian children with non-atopic asthma. Respir Med 105:S54–S59
Poon AH, Tantisira KG, Litonjua AA et al (2008) Association of corticotropin-releasing hormone receptor-2 genetic variants with acute bronchodilator response in asthma. Pharmacogenet Genomics 18:373–382
Sleiman PM, Flory J, Imielinski M et al (2010) Variants of DENND1B associated with asthma in children. N Engl J Med 362:36–44
Smit LA, Siroux V, Bouzigon E et al (2009) CD14 and toll-like receptor gene polymorphisms, country living, and asthma in adults. Am J Respir Crit Care Med 179:363–368
Taniuchi K, Nishimori I, Takeuchi T et al (2002) Developmental expression of carbonic anhydrase-related proteins VIII, X, and XI in the human brain. Neuroscience 112:93–99
Tantisira K, Weiss S (2009) The pharmacogenetics of asthma treatment. Curr Allergy Asthma Rep 9:10–17
Tantisira KG, Hwang ES, Raby BA et al (2004) TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids. Proc Natl Acad Sci U S A 101:18099–18104
Walker C, Bauer W, Braun RK et al (1994) Activated T cells and cytokines in brnochoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 150:1038–1048
Wu H, Romieu I, Sienra-Monge JJ, Li H, del Rio-Navarro BE, London SJ (2009) Genetic variation in ORM1-like 3 (ORMDL3) and gasdermin-like (GSDML) and childhood asthma. Allergy 64:629–635
Acknowledgments
This study was supported by the Slovenian research agency. Many thanks to Dr. Vojko Berce and Dr. Maja Kavalar for patients’ samples and clinical data. Special thanks to Alojz Tapajner for his help and advices in statistical analysis.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary Table 1
Conditions for PCR-RFLP reactions and fragment size after completion of test. (DOCX 16 kb)
Rights and permissions
About this article
Cite this article
Perin, P., Potočnik, U. Polymorphisms in recent GWA identified asthma genes CA10, SGK493, and CTNNA3 are associated with disease severity and treatment response in childhood asthma. Immunogenetics 66, 143–151 (2014). https://doi.org/10.1007/s00251-013-0755-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00251-013-0755-0